Request to Join
has invited you to join this group
Not ready to create an account?
Explore now and create an account later.
Accounting for 5 to 7% of all lymphomas, mantle-cell lymphoma has historically been associated with a poor outcome, but survival is improving. The epidemiology, pathology, pathophysiology, diagnosis, and treatment of mantlecell lymphoma are described.
In this trial, a restrictive approach to intravenous fluid administration in critically ill patients with septic shock did not reduce deaths at 90 days.